Certara Q3 rev $94.8M (+11% YoY); net loss narrows to $1.4M; guides FY24

Certara, Inc.

2024-Q3 EPS reported -$0.12 revenue$284,787,000

Revenue $94.8M (+11% YoY); software rev $35.9M (+15%), services rev $58.9M (+9%).
Net loss $1.4M vs $49.0M loss in Q3 2023; improvement driven by lower goodwill impairment.
Adjusted EBITDA $33.1M, up 15% from $28.8M in Q3 2023.
CEO cites Chemaxon acquisition closed; focus on integrating biosimulation platform.
Full-year 2024 financial guidance updated (specifics not provided in release snippet).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.